BLCO

Bausch & Lomb Corp

NYSEAdd to watchlist

Healthcare · Medical Instruments & Supplies

$17.55

−$0.24−1.35%

Delayed · 2026-09-10T20:00:00.000Z · marketstack

3 of 47tracked managers hold this· Q2 2026

Aug 12, 2026$17.55

+$0.79+4.71%over 1M

Day range42% of range

$17.40$17.76

Session

Previous close: $17.79
Open: $17.69
Volume: 521K
Avg volume: -
Day high: $17.76
Day low: $17.40

Fundamentals

Visualize fundamentals and more

Market cap: 6.27B
P/E ratio: -
EPS (TTM): -$0.48
Dividend yield: -
Beta: 0.55
Shares outstanding: 357.1M

Source SEC EDGAR · 9/11/2026

Tracked investors

As of Q2 2026 · 74 days ago · next update ~14 Nov 2026· what moved this quarter, onMeasure

3 fund managers this platform follows disclosed a position in BLCO, from quarterly SEC filings up to 45 days old; a manager may have sold since without yet having to say so.

Carl Icahn
Icahn Capital
$57.96M
0.70%of book
Howard Marks
Oaktree Capital Management
$56.98M
1.51%of book

1 more holder, included withMeasure

Manager	Position	Share of their book	Last change
Carl Icahn Icahn Capital	$57.96M	0.70%
Howard Marks Oaktree Capital Management	$56.98M	1.51%

1 more holder, included withMeasure

Share price, with each quarter a tracked manager’s position changed shaded across the range it traded in.

121620

now

Q2 '22

Q3 '22

Q4 '22

Q2 '25

Q3 '25

Q4 '25

Q2 '26

Hover a shaded quarter to see it moved. Who, and the range they traded in, is onBespoke

13F filings cover US-listed shares only (not cash, bonds, shorts, or private holdings) and are never a recommendation to do the same.

Risk factors, year on year

Item 1AFebruary 2026 10-KFebruary 2025as filed.

added: 47
dropped: 56
re-drafted: 51

Out of 239 passages in this year’s Item 1A.

The assistant has not been given these passages. It will say so, and say what opens them. This costs you no question.

New this year

The full Separation has not yet occurred. Unanticipated developments, including disruptions to business and commerce induced by changes in global market, financial and economic conditions (such as international conflicts and trade wars), possible delays in …

102 more passages, included withBespoke

What it says it is exposed to

From Item 1A of its most recent 10-K, filed February 2026.

Russia and Ukraine
Export controls
Data privacy
Tax
FDA approval
Litigation
Debt covenants
Goodwill impairment

And 20 more.

Russia and Ukraine
On February 24, 2022, Russia launched a military invasion of Ukraine. The ongoing military conflict between Ukraine and Russia has provoked strong reactions from the United States, the UK, the EU, Canada and various other countries around the world, including …

7 more themes, included withMeasure

Recent activity

21 more events, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like Bausch & Lomb Corp

Also filed under Medical Instruments & Supplies, ranked by how closely they sit beside BLCO.

COOCOOPER COMPANIES, INC.
ISRGINTUITIVE SURGICAL INC
BDXBECTON DICKINSON & CO
RMDRESMED INC
WSTWEST PHARMACEUTICAL SERVICES INC
RGENREPLIGEN CORP

Ask about Bausch & Lomb Corp

The assistant answers from what BLCO has actually filed: 6 annual reports filed with the SEC, 89 Form 4 filings from the last year and 13F positions from the 3 tracked investors who hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from BLCO's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding Bausch & Lomb Corp, and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with Bausch & Lomb Corp

Separate the decisions from the paperwork
Every Form 4 BLCO insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about Bausch & Lomb Corp's fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.